（於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 SHANDONG GOLD MINING CO., LTD. 山東黃金礦業股份有限公司 （股 份 代 號：1787） 2025年度業績預增公告 本公告由山東黃金礦業股份有限公司（「本公司」，連 同 其 附 屬 公 司「本集團」）根 據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及第13.10B條 以及香港法例第571章證券及期貨條例第XIVA部項下內幕消息條文（定 義 見 上 市 規 則）作 出。 重 要 內 容 提 示： 經 初 步 測 算，本 公 司 預 計2025年度實現歸屬於母公司所有者的淨利潤為人民幣 46億元至人民幣49億 元，與 上 年 同 期 相 比 增 加 人 民 幣16億元到人民幣19億 元， 同比增加56%到66%。 預 計20 ...

Core Viewpoint - Lier Chemical (002258.SZ) forecasts a significant increase in net profit for the fiscal year 2025, projecting a growth of 113.62% to 132.19% year-on-year, amounting to a net profit of 460 million to 500 million yuan [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 460 million to 500 million yuan, reflecting a year-on-year growth of 113.62% to 132.19% [1] - The net profit after deducting non-recurring gains and losses is also projected to be between 460 million to 500 million yuan, with a year-on-year increase of 129.33% to 149.28% [1] Market Factors - The increase in performance is attributed to the growth in demand for certain products, which has led to an increase in the overall gross profit margin compared to the previous year [1]

Core Viewpoint - Lier Chemical (002258.SZ) forecasts a significant increase in net profit for the fiscal year 2025, projecting a net profit attributable to shareholders of between 460 million to 500 million yuan, representing a year-on-year growth of 113.62% to 132.19% [1] Financial Performance - The company anticipates a net profit attributable to shareholders after deducting non-recurring gains and losses to also be between 460 million to 500 million yuan, with a year-on-year growth of 129.33% to 149.28% [1] - The increase in performance is attributed to the growth in demand for certain products, which has led to an increase in the overall gross profit margin compared to the previous year [1]

Core Viewpoint - China Life Insurance (02628) has shown strong performance with a projected net profit increase of 70% for the first three quarters, estimated between RMB 156.785 billion and RMB 177.689 billion, leading to a significant rise in stock price by 6.04% to HKD 24.94 [1][3]. Financial Performance - The company reported a net profit growth of 70% for Q3, with estimates ranging from RMB 156.785 billion to RMB 177.689 billion [1]. - The stock price surged to HKD 24.94, with a trading volume of HKD 4.224 billion, making it a leader in the insurance sector [1]. Market Sentiment - Analysts expect insurance stocks to perform well, supported by government encouragement for long-term capital investment since September last year [1]. - The positive market sentiment is reflected in the recent performance of China Life and Ping An (2318), both showing substantial price increases [1]. Technical Analysis - Technical indicators show mixed signals, with a sell signal strength of 8, while the RSI is at 62, indicating a 53% probability of price increase [1]. - Key support levels are identified at HKD 22.9 and HKD 22.2, while resistance levels are at HKD 26.6 and potentially HKD 27.7 if broken [1]. Derivative Products Performance - Recent call options related to China Life have performed exceptionally well, with a 58% increase in the Morgan Stanley call option (18417) and a 45% increase in the Bank of China call option (17488) [3]. - This performance highlights the potential for leveraged products in a volatile market [3]. Investment Products - Recommended call options include UBS call option (18990) and HSBC call option (19042), both with a leverage of 5.6 times and a strike price of HKD 28.05 [4]. - For bearish positions, Bank of China put option (19617) and UBS put option (19408) are suggested, with leverage of 5.9 times and 5.6 times, respectively [4].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 SHANDONG GOLD MINING CO., LTD. 山東黃金礦業股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：1787） 2025年前三季度業績預增公告 本公告由山東黃金礦業股份有限公司（「本公司」，連 同 其 附 屬 公 司「本集團」）根 據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及第13.10B條 以及香港法例第571章證券及期貨條例第XIVA部項下內幕消息條文（定 義 見 上 市 規 則）作 出。 重 要 內 容 提 示： 經 初 步 測 算，本 公 司 預 計2025年1-3季度實現歸屬於母公司所有者的淨利潤為 人民幣38.0億元至人民幣41.0億 元，與 上 年 同 期 相 比 增 加 人 民 幣17.3億元到人民 幣20.3億 元，同 比 ...